GlassScriptPhysician profile
Timothy Vavricka
NPI 1700927175
$1,129.41
in general payments reported to CMS, 2019-2025
10 companies · $571 in 2025
The $571 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2021: $31.02 · 2022: $122 · 2023: $147 · 2024: $125 · 2025: $571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $513 · Travel and Lodging: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $512.57 |
| Travel and Lodging | $329.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $467.19 | 2025 | Interstim |
| Boston Scientific Corporation | $202.97 | 2024-2025 | Overstitch Nxt Endoscopic Suturing System |
| Davol INC. | $163.97 | 2021-2023 | Phasix Mesh |
| Pacira Pharmaceuticals Incorporated | $121.61 | 2019 | |
| Lexington Medical, INC. | $108.50 | 2022 | |
| Innovation Technologies INC | $19.99 | 2025 | Irrisept |
| Allergan, INC. | $13.73 | 2021 | |
| Stryker Corporation | $13.44 | 2022 | |
| Ethicon US, LLC | $12.44 | 2019 | |
| Thd America, INC. | $5.57 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Vavricka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.